APPLICATIONS PUBLISHED 23 FEBRUARY 2005
Published: 1-Mar-2006
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Drop-forming ophthalmic gel preparation comprising diclofenamide and timolol
Dr Gerhard Mann 1507513*
Controlled release compsns of estradiol metabolites
PR Pharmaceuticals 1507514*
Free-flowing, powdery compsn containing alpha-liponic acid (-derivatives)
Degussa 1507515*
Co-grinding process for the preparation of a ternary compsn
Actimex 1507516*
Microparticles bearing cells and active substances
INSERM 1507517*
Combination immediate release controlled release levodopa/carbidopa dosage forms
Impax Laboratories 1507518*
Medicament with delayed release of the active substance, containing 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol
Gruenenthal 1507519*
Combination of selected opioids with other active substances for use in the therapy of urinary incontinence
Gruenenthal 1507520*
Metabolite of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and the use thereof in the treatment of urinary incontinence
Gruenenthal 1507521*
Method of treating vascular endothelial growth factor mediated vascular disorders using Amfenac or Nepafenac
Alcon 1507522*
Cinnamic acid dimers, their preparation and use thereof for treating neurodegenerative disease
Korea Institute of Science and Technology 1507523*
Use of diuretics for treating swellings
Wank, Rudolf 1507524*
Non-steroidal anti-androgen therapy
AstraZeneca 1507525*
Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services 1507526*
Methods for enhancing motor performance and/or endurance
Oklahoma Medical Research Foundation 1507527*
Methods for using JNK inhibitors for treating or preventing disease-related wasting
Signal Pharmaceuticals 1507528*
Combination of organic compounds
Novartis 1507529*
Diaminothiazoles
F Hoffmann-La Roche 1507530*
Stable pharmaceutical compsns of desloratadine
Biogal Gyogyszergyar 1507531*
Utilisation of quinoline derivatives with anti-integrase effect and applications thereof
Bioalliance Pharma; Centre National de la Recherche Scientifique 1507532*
Heteroalkyl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins
Elan Pharmaceuticals 1507533*
Compounds, compsns and methods
Cytokinetics 1507534*
Pyrimidine-2,4,6-trione metallo-proteinase inhibitors
Pfizer 1507535*
Compsns and their use for alleviating pain
Allergan 1507537*
Combination of an ACE inhibitor, a calcium channel blocker and a diuretic
Novartis 1507537*
Norethindrone sustained release formulations and methods associated therewith
Watson Pharmaceuticals 1507538*
Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
Wyeth 1507538*
Nucleic acid vaccines using tumour antigen encoding nucleic acids with cytokine adjuvant encoding nucleic acids
Centocor 1507540*
Inhibitors and methods of use thereof
Trustees of Dartmouth College 1507541*
Anticancer formulation
Greystone Medical Group 1507542*
A pharmaceutical compsn for treatment of wounds containing blood plasma or serum
Medigenes 1507543*
Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng
Md Bioalpha 1507544*
A terpene-based compsn of substances, a methods for its preparation, and a method for its dispersal into the atmosphere
Turispharma 1507545*
Methods of using 22417, a novel human aminoprotease family member
Millennium Pharmaceuticals 1507546*
Peptides for regulation of urokinase (UPA) and tissue type (TPA) plasminogen activator and method of optimising therapeutic efficacy
Thrombotech 1507547*
Method for determining immune system affecting compounds
Östergoetlands Laens Landsting 1507548*
Drug therapy for celiac sprue
The Board of Trustees of the Leland Stanford Junior University 1507549*
Suicide tetramers comprising MHC class 1 and uses thereof
Sloan Kettering Institute for Cancer Research 1507550*
The functional role of PACAP, VIP and maxadilan in relation to adult neural stem or progenitor cells
Neuranova 1507551*
Methods, compsns and growth and differentiation factors for insulin-producing cells
Novocell 1507552*
Pancreas-specific proteins
DeveloGen 1507553*
Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
Agennix 1507554*
Induction of antigen specific immunologic tolerance
Biomarin Pharmaceutical; Harbor-UCLA Research & Education Institute 1507555*
Calicheamin derivative-carrier conjugates
Wyeth 1507556*
Methods and devices for targeting a site in a mammal and for removing species from a mammal
Strahilevitz, Meir 1507557*
Pharmaceutical compsn comprising a renin inhibitor, a calcium channel blocker and a diuretic
Novartis 1507558*
Delivery of microparticle-conjugated drugs for inhibition of stenosis
Avi Biopharma 1507559*
Immune stimulating and controlling compsn comprising bacterial chromosomal DNA fragments and non-toxic lipopolysaccharides
Eyegene 1507560*
Compsns for delivering nucleic acids to cells
Minus Corp 1507561*
Methoda and compsns for radioimmunotherapy of brain and CNS tumours
Immunomedics 1507562*
Endotoxin-binding ligands and their use
Prometic Biosciences 1507563*
Water-absorbing polymer particles inhibiting the breakdown of body fluids, composites comprising the same and use thereof
Stockhausen 1507564*
Disposable injection device designed to be pre-filled
MB Innovation 1507565*
Use of docetaxelidoxorubicin/cyclophosphamaide in adjuvant therapy of breast and ovarian cancer
Aventis Pharma 1507573*
Separation column having a photopolymerised sol-gel component and associated methods
The Board of Trustees of the Leland Stanford Junior University 1507574*
Methods and devices utilising adsorption of chiral molecules at a surface or interface
The University of Liverpool 1507575*
Alkoxy aryl beta-2 adrenergic receptor agonists
Theravance 1507754*
Novel monofunctional polyethylene glycol aldehydes
Sun Bio 1507755*
CCR9 inhibitors and methods of use thereof
Millennium Pharmaceuticals 1507756*
Lactams used as antiviral agents
Bayer HealthCare 1507757*
Indole derivatives and their use as ligands for CB2 receptors
Sanofi-Aventis 1507758*
Cyanoguanidine prodrugs
Leo Pharma 1507759*
Cyanoguanidine prodrugs
Leo Pharma 1507760*
Tetrahydroisoquinoline derivatives
Bayer HealthCare 1507763*
Novel enantiomers of tetrahydroisoquinoline derivatives and their pharmaceutically acceptable salts, their preparations and pharmaceutical compsns
Yun-Choi, Hye-Sook; Chang, Ki-Churl; Lee, Duck-Hyung 1507764*
Methods and compsns for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
Israel Institute for Biological Research 1507765*
Synthesis of diaryl pyrazoles
Pharmacia Corp 1507766*
4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2B and alpha-2C adrenergic receptors
Allergan 1507767*
Copper-catalysed ligation of azides and acetylenes
The Scripps Research Institute 1507769*
Isothiazolone compsn and method for stabilising isothiazolone
SK Chemicals 1507771*
Method of using thiazolidinedithione derivatives
QLT 1507772*
Macrocyclic compounds useful as pharmaceuticals
Eisai 1507773*
Processes for preparation of polymorphic forms of desloratadine
Biogal Gyogyszergyar 1507774*
Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha-4-integrins
Elan Pharmaceuticals 1507775*
2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders
Amgen 1507776*
Process for preparing crystalline form I of cabergoline
Pharmacia 1507777*
Anti-tumour polycyclic carboxamides
La Trobe University; Auckland University 1507778*
Inhibitors of JAK and CDK1 protein kinases
Vertex Pharmaceuticals 1507779*
Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
Bristol-Myers Squibb 1507780*
Process for preparing maytanisol
SmithKline Beecham 1507781*
Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
Centre National de la Recherche Scientifique 1507794*
Tumour-associated peptides that bond to MHC molecules
Immatics Biotechnologies 1507795*
Cross-linked glycopeptide-cephalosporin antibiotics
Theravance 1507796*
Inhibitors of proteins from the RHO-GEF family
Centre National de la Recherche Scientifique 1507797*
Export and modification of (poly)peptides in the antibiotic way
Applied Nanosystems 1507798*
Novel cyclic peptides and use thereof as anti-microbial agents
Centre National de la Recherche Scientifique 1507799*
Use of monocarboxylate transporter protein for thyroid hormone transport
Stichting tot bevordering van de wetenschap der Endocrinologie 1507800*
Antibodies and their use for the modulation of taste sensation
TVD Taste Virtual Dimensions 1507801*
Transformed fungi for the production of recombinant proteins
Universite Laval 1507802*
Method for the treatment of starch
Ciba Specialty Chemicals 1507803*
Use of carbamate containing protective reagents for chemical modifications, their production and use
Medical Enzymes 1507804*
